Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Diabetes and infectious disease mortality in Mexico City.

Journal article

Bragg F. et al, (2023), BMJ open diabetes research & care, 11

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.

Journal article

Donovan K. et al, (2023), Clin J Am Soc Nephrol, 18, 17 - 27

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.

Journal article

Nuffield Department of Population Health Renal Studies Group None. and SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium None., (2022), Lancet, 400, 1788 - 1801

Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults.

Journal article

Aguilar-Ramirez D. et al, (2022), Commun Med (Lond), 2

Empagliflozin in Patients with Chronic Kidney Disease.

Journal article

EMPA-KIDNEY Collaborative Group None. et al, (2022), N Engl J Med

Bioimpedance in CKD: an Untapped Resource?

Journal article

HERRINGTON W. and Mayne K., (2022), Nephrology Dialysis Transplantation

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial.

Journal article

EMPA-KIDNEY Collaborative Group None., (2022), Nephrol Dial Transplant, 37, 1317 - 1329

Body mass index and COVID-19 mortality: prospective study of 120 000 Mexican adults.

Journal article

Alegre-Díaz J. et al, (2022), Int J Epidemiol

In CKD, the Kidney Failure Risk Equation predicted 2-y risk for ESKD better than eGFR alone.

Journal article

Aguilar-Ramirez D. and Herrington WG., (2022), Ann Intern Med

In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes.

Journal article

Mayne KJ. and Herrington WG., (2022), Annals of internal medicine, 175

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

Load More